BlossomHill Therapeutics, Inc.

CIK 1839970 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BlossomHill Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 18, 2026SCHEDULE 13D0000947871-26-000813
Aug 17, 2026SCHEDULE 13G0001213900-26-090726
Aug 14, 2026SCHEDULE 13G0001193125-26-352634
Aug 13, 2026SCHEDULE 13D0000929638-26-003026
Aug 12, 202640000947871-26-000785
Aug 12, 202640000947871-26-000784
Aug 10, 2026S-80001193125-26-342572
Aug 10, 202640001678152-26-000003
Aug 10, 202640001282930-26-000008
Aug 10, 202640001772233-26-000005
Aug 10, 202640001478916-26-000015
Aug 10, 202640002144320-26-000003
Aug 10, 202640001840599-26-000003
Aug 10, 202640001231919-26-000852
Aug 10, 20268-K0001193125-26-342316
Aug 10, 202640001772259-26-000005
Aug 10, 202640002143905-26-000003
Aug 7, 2026424B40001193125-26-340215
Aug 6, 202630002143905-26-000002
Aug 6, 2026CERT0001354457-26-000767
Aug 6, 2026S-1MEF0001193125-26-338734
Aug 6, 202630001772259-26-000004
Aug 6, 202630001772233-26-000004
Aug 6, 202630001678152-26-000002
Aug 6, 202630001282930-26-000007